SEC Filing Reveals Details of Avalanche Biotechnologies' Equity Securities

Avalanche Biotechnologies, a biotechnology company with a focus on biological products, filed a Form 4 document with the U.S. Securities and Exchange Commission (SEC) on May 7, 2015. The filing provided insights into the company's equity securities and the relationship between its directors, officers, and major shareholders. The document also shed light on the company's business operations and financial dealings. According to the SEC filing, Avalanche Biotechnologies' SIC code is 2836, indicating that the company operates in the biological products industry.

Key Takeaways:

Avalanche Biotechnologies filed a Form 4 document with the SEC on May 7, 2015, providing information on the company's equity securities and the relationship between its directors, officers, and major shareholders.
The company's SIC code is 2836, indicating that it operates in the biological products industry.
The Form 4 filing contains information on purchases and sales of equity securities by the company's directors, officers, and major shareholders.
The annual statement of beneficial ownership of securities is required to be filed on Form 5 by the company's directors, officers, and major shareholders.
The forms contain information on the reporting person's relationship to the company and on purchases and sales of equity securities.
The SEC filing is a formal document or financial statement submitted to the SEC by publicly-traded companies.

Statistics:

The SIC code for Avalanche Biotechnologies is 2836, indicating that the company operates in the biological products industry.
The company's SEC filing was made on May 7, 2015.
The SEC file number for the filing is 0001209191-15-039953.

Sources:

SEC Filing Form 4 (Avalanche Biotechnologies, Inc., Reg. No. 1501756, File Number: 0001209191-15-039953)
SEC website (http://www.sec.gov/Archives/edgar/data/1501756/0001209191-15-039953-index.html)